In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance.

[1]  V. Klauss,et al.  Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. , 1996, Ophthalmology.

[2]  K. Bower,et al.  Fluoroquinolones in the treatment of bacterial keratitis. , 1996, American journal of ophthalmology.

[3]  D. Fong,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. , 1996, Archives of ophthalmology.

[4]  M. Viana,et al.  Differential care of corneal ulcers in the community based on apparent severity. , 1996, Ophthalmology.

[5]  P M Southern,et al.  Susceptibility of Corneal and Conjunctival Pathogens to Ciprofloxacin , 1996, Cornea.

[6]  M. Maguire,et al.  Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. , 1995, Archives of ophthalmology.

[7]  K. Wilhelmus,et al.  0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group. , 1993, Archives of ophthalmology.

[8]  D. O'day,et al.  Ciprofloxacin-resistant bacterial keratitis. , 1993, American journal of ophthalmology.

[9]  D. J. Parks,et al.  Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis. , 1993, American journal of ophthalmology.

[10]  M. Snyder,et al.  Ciprofloxacin-resistant bacterial keratitis. , 1992, American journal of ophthalmology.

[11]  Neu Hc.  Microbiologic aspects of fluoroquinolones. , 1991 .

[12]  Hyndiuk Ra,et al.  Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. , 1991 .

[13]  H. Leibowitz.  Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. , 1991, American journal of ophthalmology.

[14]  R. Steinert.  Current therapy for bacterial keratitis and bacterial conjunctivitis. , 1991, American journal of ophthalmology.

[15]  J. Snyder,et al.  An in vitro study of the potency and stability of fortified ophthalmic antibiotic preparations. , 1991, American journal of ophthalmology.

[16]  G. Kaatz,et al.  Mechanism of ciprofloxacin resistance in Pseudomonas aeruginosa. , 1988, The Journal of infectious diseases.

[17]  J. Smith.  The mode of action of 4-quinolones and possible mechanisms of resistance. , 1986, The Journal of antimicrobial chemotherapy.

[18]  J. Baum,et al.  The stability of ten antibiotics in artificial tear solutions. , 1976, American journal of ophthalmology.